Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 37 Colorectal Neoplasms 28 Leukemia, Myeloid, Acute 27 Neoplasms 26 Recurrence 22 Neoplasm Metastasis 22 Multiple Myeloma 20 Advanced Solid Tumors 20 Lymphoma, B-Cell 19 Breast Neoplasms 17 Pancreatic Neoplasms 14 Lung Neoplasms 13 Glioblastoma 13 Carcinoma, Hepatocellular 13 Brain Neoplasms 13 Lymphoma 12 Glioma 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Melanoma 11 Hematologic Neoplasms 11 Triple Negative Breast Neoplasms 10 Squamous Cell Carcinoma of Head and Neck 10 Ovarian Neoplasms 10 Leukemia 10 Advanced Solid Tumor 10 Prostatic Neoplasms 9 Head and Neck Neoplasms 9 Lymphoma, Non-Hodgkin 8 Esophageal Neoplasms 8 Sarcoma 7

Interventions

bemarituzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Not yet recruiting × GastroEsophageal Cancer × Clear all

NCT06978062 2025-06-05

NeoBEMA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Not yet recruiting

Gastrointestinal

GastroEsophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡